Investigation of fat mass and obesity associated (FTO) gene polymorphism in Romanian population

Biointerface Research in Applied Chemistry

Volumn 8, Issue 6, 2018, Pages 3710-3718

  Stanislav, Alexandra Alina ^a   Vassu Dimov, Tatiana ^a   Iacob, Mirela Maria ^a,b   Botezatu, Anca ^c   Arsene, Cosmin ^a,d   Burlibasa, Liliana ^a,d   Bodron, Paul ^a   Sarghie, Larisa ^a   Cucu, Natalia ^a,d   Alexandrescu, Lygia ^e  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b Clinical Institute Fundeni   (Romania)

^c STEFAN S NICOLAU INSTITUTE OF VIROLOGY   (Romania)

^d Association for Epigenetics and Metabolomics   (Romania)

^e The Association for Education in Nutrition   (Romania)

Author keywords

BMI; Epigenetic; FTO gene; Genotype; Obesity; Single nucleotide polymorphism

Indexed keywords

EID: 85058676827     PISSN: None     EISSN: 20695837     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Lewis C.E., McTigue K.M., Burke L.E., Poirier P., Eckel R.H., Howard BV.., Allison D.B., Kumanyika S., Pi-Sunyer F.X., Mortality, health outcomes, and body mass index in the overweight range: a science advisory from the American Heart Association, Circulation, 119, 3263-7, 2009.
2. Hetherington M.M., Cecil J.E., Gene-environment interactions in obesity, Forum Nutr., 63, 195-203, 2010.
3. Taylor A.E., Ebrahim S., Ben-Shlomo Y., Martin R.M., Whincup P.H., Yarnell J.W., Wannamethee S.G., Lawlor D.A., Comparison of the associations of body mass index and measures of central adiposity and fatt mass with coronary heart disease, diabetes, and all-causes of mortality: a study using data from 4 UK cohorts, Am J Clin Nutr, 91, 547-56, 2010.
4. Loos R.J.F., Bouchard C., Obesity – is it a genetic disorder?, J Intern Med, 254, 401–425, 2003.
5. Maes HH, Neale MC, Eaves LJ, “Genetic and environmental factors in relative body weight and human adiposity”, Behav Genet, 27: 325-51, 1997.
6. Speliotes E.K., et al., Association Analyses of 249,796 Individuals Reveal Eighteen New Loci Associated with Body Mass Index, NatGenetics, 42, 11, 937–948, 2010.
7. Loos R.J., et al., Common variants near MC4R are associated with fat mass, weight and risk of obesity”, Nat Genet, 40, 768-75, 2008.
8. Willer C.J., et al., Six new loci associated with body mass index highlight a neuronal influence on body weight regulation, Nat Genetics, 41, 25-34, 2009.
9. Thorleifsson G., Walters G.B., Gudbjartsson D.F., Steinthorsdottir V., Sulem P., Helgadottir A., Styrkarsdottir U., Gretarsdottir S., Thorlacius S., Jonsdottir I., Jonsdottir T., Olafsdottir E.J., Olafsdottir G.H., Jonsson T., Jonsson F., Borch-Johnsen K., Hansen T., Andersen G., Jorgensen T., Lauritzen T., Aben K.K., Verbeek A.L., Roeleveld N., Kampman E., Yanek L.R., Becker L.C., Tryggvadottir L., Rafnar T., Becker D.M., Gulcher J., Kiemeney L.A., Pedersen O., Kong A., Thorsteinsdottir U., Stefansson K., Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity, Nat Genetics, 41, 18-24, 2009.
10. Ren D., Zhou Y., Morris D., Li M., Li Z., Rui L., Neuronal SH2B1 is essential for controlling energy and glucose homeostasis, J Clin Invest, 117, 397-406, 2007.
11. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F., Targeted disruption of the melanocortin-4 receptor results in obesity in mice, Cell, 88, 131-41, 1997.
12. O’Rahilly S., Farooqi I.S., Human obesity as a veritable disorder of the central control of energy balance, Int J Obes (Lond), 32, 7, 55-61, 2008.
13. Lindgren C.M., et al., Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution, PLoS Genet, 5, 1000508, 2009.
14. Hirschhorn J.N., Genome-wide association studies-illuminating biologic pathways, N Engl J Med, 360,1699-701, 2009.
15. Hsiao T.J., Hwang Y., Chang H.M., Lin E., Association of the rs6235 variant in the proprotein convertase subtilisin/kexin type 1 (PCSK1) gene with obesity and related traits in a Taiwanese population, Gene, 533, 32-37, 2014.
16. Hsiao T.J., Hwang Y., Liu C.H., Chang H.M., Lin E., Association of the C825T polymorphism in the GNB3 gene with obesity and metabolic phenotypes in a Taiwanese population, GenesNutr, 8, 137-44, 2013.
17. Bouchard C., Perusse L., Current status of the human obesity gene map, Obes Res., 4, 81–90, 1996.
18. Rankinen T., Zuberi A., Chagnon Y.C., The human obesity gene map: the 2005 update, Obesity (Silver Spring), 14, 4, 529–644, 2006.
19. Loos R.J., Genetic determinants of common obesity and their value in prediction”, Best Practice & Research Clinical Endocrinology & Metabolis, 26, 2, 211 – 226, 2012.
20. Loos R.J., Recent Progress in the Genetics of Common Obesity, British Journal of Clinical Pharmacology, 68, 6, 811–829. 2009.
21. Loos R.J., Yeo G.S., The bigger picture of FTO:the first GWAS-identified obesity gene, Nat Rev Endocrinol, 10, 1, 51-61, 2014.
22. Frayling T.M., Timpson N.J., Weedon M.N., Zeggini E., Freathy R.M., Lindgren C.M., Perry J.R., Elliott K.S., Lango H., Rayner NW.., Shields B., Harries L.W., Barrett J.C., Ellard S., Groves C.J., Knight B., Patch A.M., Ness A.R., Ebrahim S., Lawlor D.A., Ring S.M., Ben-Shlomo Y., Jarvelin M.R., Sovio U., Bennett A.J., Melzer D., Ferrucci L., Loos R.J., Barroso I., Wareham N.J., Karpe F., Owen K.R., Cardon L.R., Walker M., Hitman G.A., Palmer C.N., Doney A.S., Morris A.D., Smith G.D., Hattersley A.T., McCarthy M.I., A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity, Science (New York, N.Y.),316, 5826, 889–894, 2007.
23. Scuteri A., Sanna S., Chen W.M., Uda M., Albai G., Strait J., Najjar S., Nagaraja R., Orrú M., Usala G., Dei M., Lai S., Maschio A., Busonero F., Mulas A., Ehret G.B., Fink A.A., Weder A.B., Cooper R.S., Galan P., Chakravarti A., Schlessinger D., Cao A., Lakatta E., Abecasis G.R., Genome-Wide Association Scan Shows Genetic Variants in the FTO Gene Are Associated with Obesity-Related Traits, Ed. Greg Barsh. PLoS Genetics, 3, 7, 115, 2007.
24. Fawcett K.A., Barroso I., The Genetics of Obesity: FTO Leads the Way, Trends in Genetics, 26, 6, 266–274, 2010.
25. Peeters A., Beckers S., Verrijken A., Roevens P., Peeters P., Van Gaal L., Van Hul W.P.I, Variants in the FTO gene are associated with common obesity in the Belgian population”, Molecular genetics and metabolism, 93, 4, 481-4, 2008.
26. Price R.A., Li W.D., Zhao H.Y., FTO gene SNPs associated with extreme obesity in cases, controls and extremely discordant sister pairs, IBMC Med Genet, 9, 4-11, 2008.
27. Legry V., Cottel D., Ferrieres J., Arveiller D., Andrieux N., Bingham A., Wagner A., Ruidavets J.B., Ducimetière P., Amouyel P., Meirhaeghe A., Effect of an FTO polymorphism on fat mass, obesity, and type 2 diabetes mellitus in the French MONICA study, Metabolism, 58, 971-975, 2009.
28. Chang Y.C., Liu P.H., Lee W.J., Chang T.J., Jiang Y.D., Li H.Y., Shan K.S., Lee K.C., Chuang L.M., Common variation in the fat mass and obesity associated (FTO) gene confers risk of obesity and modulates BMI in Chinese population, Diabetes, 57, 2245-2252, 2008.
29. Sebert S., Salonurmi T., Keinanen-Kiukaanniemi S., Savolainen M., Herzig K.H., Symonds M.E., Jarvelin M.R., Programming effects of FTO in the development of obesity, Acta Pgysiol Oxf, 210, 1, 58-69, 2014.
30. Gerken T., Girard C.A., Tung Y.C., Webby C.J., Saudek V., Hewitson K.S., Yeo G.S., McDonough M.A., Cunlife S., McNeill L.A., Galvanovskis J., Rorsman P., Robins P., Prieur X., Coll A.P., Ma M., Jovanovic Z., Farooqi I.S., Sedgwick B., Barroso I., Lindahl T., Ponting C.P., Ashcroft F.M., O'Rahilly S., Schofield C.J., The obesity associated FTO gene encodes a 2-oxoglucarate-dependent nucleic acid demethylase, Science, 318, 5855, 1469-72, 2007.
31. Smemo S., Tena J.J., Kim K.H., Gamazon E.R., Sakabe N.J., Gómez-Marín C., Aneas I., Credidio F.L., Sobreira D.R., Wasserman N.F., Lee J.H., Puviindran V., Tam D., Shen M., Son J.E., Vakili N.A., Sung H.K., Naranjo S., Acemel R.D., Manzanares M., Nagy A., Cox N.J., Hui C.C., Gomez-Skarmeta J.L., Nóbrega M.A., Obesity-Associated Variants within FTO Form Long-Range Functional Connections with IRX3, Nature, 507, 7492, 371–375, 2014.
32. Church C., Moir L., McMurray F., Girard C., Banks G.T., Teboul L., Wells S., Brüning J.C., Nolan P.M., Ashcroft F.M., Cox R.D., Overexpression of Fto Leads to Increased Food Intake and Results in Obesity, Nature genetics, 42, 12, 1086–1092. 2010.
33. Herrera B.M., Keildson S., Lindgren C.M., Genetics and Epigenetics of Obesity, Maturitas, 69, 1, 41–49, 2011.
34. Zhu T., Yong L.H.X., Xia D., Widagdo J., Anggono V., Ubiquitination Regulates the Proteasomal Degradation and Nuclear Translocation of the Fat Mass and Obesity-Associated (FTO) Protein, Journal of Molecular Biology, 430, 3, 363-371, 2017.
35. Sanchez-Pulido L., Andrade-Navarro M.A., The FTO (fat mass and obesity associated) gene encodes for a novel member of the non-hemedioxygenase superfamily, BMC Biochem, 8, 23-32, 2007.
36. 6-Methyladenosine in Nuclear RNA Is a Major Substrate of the Obesity-Associated FTO, Nature chemical biology, 7, 12, 885–887, 2011.
37. Meyer K.D., Jaffrey S.R., The dynamic epitranscriptome: N6-methyladenosine and gene expression control, Nat Rev Mol Cell Biol, 15, 5, 313-26, 2014.
38. Speakman J.R., The “Fat Mass and Obesity Related” (FTO) gene: Mechanisms of Impact on Obesity and Energy Balance, CurrObes Rep, 4, 1, 73-91, 2015.
39. Gulati P., Yeo G.S., The Biology of FTO: From Nucleic Acid Demethylase to Amino Acid Sensor, Diabetologia, 56, 10, 2113–2121, 2013.
40. Lu Y., Loos R.J., Obesity genomics: assessing the transferability of susceptibility loci across diverse populations, Genome Med, 5, 6, 55-70, 2013.
41. Jacobson J.A., Schioth H.B., Fredriksson R., The impact of intronic single nucleotide polymorphisms and ethnic diversity for studies on the obesity gene FTO, Obes Rev, 13, 12, 1096-109, 2012.
42. Harbron J., van der Merwe L., Zaahl M.G., Kotze M.J., Senekal M., Fat Mass and Obesity-Associated (FTO) Gene Polymorphisms Are Associated with Physical Activity, Food Intake, Eating Behaviors, Psychological Health, and Modeled Change in Body Mass Index in Overweight/Obese Caucasian Adults, Nutrients, 6, 8, 3130–3152, 2014.
43. Hunt S.C., Stone S., Xin Y., Scherer C.A., Magness C.L., Iadonato S.P., Hopkins P.N., Adams T.D., Association of the FTO Gene with BMI, Obesity (Silver Spring, Md.), 16, 4, 902–904, 2008.
44. Jacobson J.A., Schioth H.B., Fredriksson R., The impact of intronic single nucleotide polymorphisms and ethnic diversity for studies on the obesity gene FTO, Obes Rev, 13, 12, 1096-109, 2012.
45. Marginean O., Banescu C., Marginean M., Tripon F., Crauciuc G., O-050 The Role Of Fto Rs17817449 And Rs 9939609 Snp (single Nucleotide Polymorphism) In Children’ Obesity, Archives of Disease in Childhood, 99A, 41, 2014.
46. Ursu R.I., Badiu C., Cucu N., Ursu G.F., Craciunescu I., Severin E., The Study of the rs9939609 FTO Gene Polymorphism in Association with Obesity and the Management of Obesity in a Romanian Cohort, Journal of Medicine and Life, 8, 2, 232–238, 2015.
47. Ursu R.I., Cucu N., Ursu G.F., Craciunescu I., Severin E., Puiu M., Alexandrescu L., Frequency Study of the FTO and ADRB3 Genotypes in a Romanian Cohort of Obese Children, Rom Biotech Lett, 21, 3, 2016.
48. Arsene C., Ursu R.I., Dan V., Trifanescu R., Badiu C., Niculescu M., Puiu M., Alexandrescu L., Cucu N., A fully automated method for FTO and ADRB3 genotyping in syndromic (Prader-Willi Syndrome) and common obesity, Roum Biotech Lett, 22, 6, 2016.
49. Duicu C., Mărginean C.O., Voidăzan S., Tripon F., Bănescu C., FTO Rs 9939609 SNP Is Associated with Adiponectin and Leptin Levels and the Risk of Obesity in a Cohort of Romanian Children Population, Ed. Ana Raimunda Dâmaso. Medicine, 95, 20, 3709, 2016.
50. Claussnitzer M., Dankel S.N., Kim K.H., Quon G., Meuleman W., Haugen C., Glunk V., Sousa I.S., Beaudry J.L., Puviindran V., Abdennur N.A., Liu J., Svensson P.A., Hsu Y.H., Drucker D.J., Mellgren G., Hui C.C., Hauner H., Kellis M., FTO obesity variant circuitry and adipocyte browning in humans, N Engl J Med., 373, 895–907, 2015.
51. Graff M., Gordon-Larsen P., Lim U., Fowke J.H., Love S.A., Fesinmeyer M., Wilkens L.R., Vertilus S., Ritchie M.D., Prentice R.L., Pankow J., Monroe K., Manson J.E., Le Marchand L., Kuller L.H., Kolonel L.N., Hong C.P., Henderson B.E., Haessler J., Gross M.D., Goodloe R., Franceschini N., Carlson C.S., Buyske S., Bůžková P., Hindorff L.A., Matise T.C., Crawford D.C., Haiman C.A., Peters U., North K.E., The influence of obesity related single nucleotide polymorphisms on BMI across the life course: the PAGE study, Diabetes, 62, 5, 1763±7, 2013.
52. Sandholt C.H., Pedersen O., Beige adipocytes—will they beat obesity?, Nature Reviews Endocrinology, 11, 694–696, 2015.
53. Yang Q., Xiao T., Guo J., Su Z., Complex Relationship between Obesity and the Fat Mass and Obesity Locus, Int J BiolSci, 13, 5, 615-629, 2017.
54. Herman M.A., Rosen E.D., Making Biological Sense of GWAS Data: Lessons from the FTO Locus, Cell Metabolism, 6, 538-539, 2015.
55. Zou Y., Lu P., Shi J., Liu W., Yang M., Zhao S., Chen N., Chen M., Sun Y., Gao A., Chen Q., Zhang Z., Ma Q., Ning T., Ying X., Jin J., Deng X., Shen B., Zhang Y., Yuan B., Kauderer S., Liu S., Hong J., Liu R., Ning G., Wang Q., Gu W., Wang J., IRX3 Promotes the Browning of White Adipocytes and Its Rare Variants are Associated with Human Obesity Risk, EBioMedicine, 24, 64–75, 2017.
56. Inagaki T., Regulations of Adipocyte Phenotype and Obesity by IRX3. Positive or Negative?, EBioMedicine, 24, 7–8, 2017.
57. Smemo S., Tena J.J., Kim K.H., Gamazon E.R., Sakabe N.J., Gomez-Marn C., Aneas I., Credidio F.L., Sobreira D.R., Wasserman N.F., Lee J.H., Puviindran V., Tam D., Shen M., Son J.E., Vakili N.A., Sung H.K., Naranjo S., Acemel R.D., Manzanares M., Nagy A., Cox N.J., Hui C.C., Gomez-Skarmeta J.L., No brega M.A., Obesity-associated variants within FTO form long-range functional connections with IRX3, Nature, 507, 375, 2014.